Ocular drug delivery systems (Record no. 10437)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | nam a22 7a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20211216114732.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 191205b xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781439848005 |
| Qualifying information | CRC website |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780367269265 |
| Qualifying information | Indian edition |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | AIKTC-KRRC |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | ENG |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Edition number | DDC23 |
| Classification number | 617.7061 |
| Item number | THA/CHA |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 4175 |
| Personal name | Thassu, Deepak |
| Relator term | Editor |
| 245 ## - TITLE STATEMENT | |
| Title | Ocular drug delivery systems |
| Remainder of title | : Barriers and application of nanoparticulate systems |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Boca Raton |
| Name of publisher, distributor, etc. | CRC Press |
| Date of publication, distribution, etc. | 2013 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | xv, 447p. |
| Other physical details | | Binding- Hard Bound | |
| Dimensions | 23.5*16 cm |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Drug discovery for ocular diseases has taken great strides in the last two decades. From cornea to choroid, new drugs have been formulated to address a great variety of ocular diseases. Yet without good drug delivery systems, these drugs are less effective than they might be or could even cause serious side effects. Ocular Drug Delivery Systems: Barriers and Application of Nanoparticulate Systems presents research on the development of currently marketed devices and recent trends in the topical delivery of drugs to the posterior of the eye.<br/><br/>With contributions from leading pharmaceutical researchers and industry experts, eye researchers, surgeons, pharmacologists from academia, the National Eye Institute, and leading ophthalmic companies such as Pfizer, Allergan, and Novartis, the book presents the state of the art in the use of nanoparticles in ocular drug delivery systems and also sets the stage for future developments.<br/><br/>This volume provides both a current evaluation and a future roadmap for developments in ocular drug delivery. The subjects range from biological needs to material challenges and finally to clinical applications for improving drug delivery for conditions where treatments already exist. It also explores areas where effective drugs may be currently available but yet need a safe, efficient, and efficacious delivery vehicle. |
| Expansion of summary note | Table of Contents<br/><br/>Basic Considerations<br/>Nanoparticle-Based Therapeutics: An Overview<br/>Deepak Thassu, Kris Holt, and Gerald J. Chader<br/>Eye Anatomy, Physiology and Ocular Barriers: Basic Considerations for Drug Delivery<br/>Gerald J. Chader and Deepak Thassu<br/>Animal Models to Evaluate Ocular Nanoparticular Drug Delivery Systems<br/>Vinson M. Wang, Jingsheng Tuo, and Chi-Chao Chan<br/>Computer Modeling for Ocular Drug Delivery<br/>Paul J. Missel<br/>Challenges in the Development of Nanotechnology-Based Ophthalmic Systems<br/>Banu S. Zolnik, Sheriza Baksh, and Nakissa Sadrieh<br/><br/>Ocular Barriers<br/>Blood–Retinal Barrier: The Fundamentals<br/>Rosa Fernandes, Andreia Gonçalves, and José Cunha-Vaz<br/>Barriers to Transscleral Drug Delivery to the Retina<br/>Alexandra Almazan, Susan S. Lee, Aron D. Ross, and Michael R. Robinson<br/><br/>Ocular Compartment Drug Delivery<br/>Drug Delivery to the Vitreous Humor<br/>Francine Behar-Cohen<br/>Transscleral and Suprachoroidal Drug Delivery<br/>Damian E. Berezovsky and Henry F. Edelhauser<br/>Protein Drug Delivery to Retina and Choroid<br/>Hongwen M. Rivers and Patrick M. Hughes<br/>Transscleral Drug Delivery to the Posterior Segment of the Eye<br/>Bernard F. Godley, Cheryl L. Rowe-Rendleman, Ed Kraft, and Gabriella Kulp<br/>Drug Delivery to the Suprachoroidal Space<br/>Sung Won Cho and Timothy W. Olsen<br/>Use of Nanoparticles in the Treatment of Age-Related Macular Degeneration, Glaucoma, and Other Degenerative Retinal Diseases<br/>Marco A. Zarbin, Carlo Montemagno, James F. Leary, and Robert Ritch<br/><br/>Drug Delivery Systems<br/>Drug Molecule Characteristics, Drug Delivery Strategies and Their Impact on Ophthalmic Drug Delivery to Anterior versus Posterior Segments<br/>Kay D. Rittenhouse<br/>Surface Modulation of Nanoparticles<br/>Deepak Thassu and Kris Holt<br/>Nanoparticles for the Treatment of Retinal Diseases<br/>Amin Famili and Uday B. Kompella<br/>Gene-Based Medicine for Ocular Diseases<br/>Shannon M. Conley and Muna I. Naash<br/>Stealth-Type Polymeric Nanoparticles with Encapsulated Betamethasone Phosphate for Treatment of Intraocular Inflammation<br/>Tsutomu Sakai, Tsutomu Ishihara, and Megumu Higaki<br/><br/>Technology and Materials Development<br/>Nanotechnology-Guided Imaging of Retinal Vascular Disease<br/>Joshua R. Trantum and Ashwath Jayagopal<br/>Photoresponsive Polymers for Ocular Drug Delivery<br/>Laura A. Wells and Heather Sheardown<br/>Nanosuspensions in Ocular Drug Delivery Systems<br/>Himanshu Bhattacharjee and Sonia Bedi |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| 9 (RLIN) | 7371 |
| Topical term or geographic name entry element | PHARMACOTHERAPEUTICS |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | THERAPEUTICS |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 11019 |
| Personal name | Chader, Gerald J. |
| Relator term | Editor |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Books |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection code | Home library | Current library | Shelving location | Date acquired | Source of acquisition | Cost, normal purchase price | Total Checkouts | Full call number | Barcode | Date last seen | Date last checked out | Cost, replacement price | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dewey Decimal Classification | Reference | School of Pharmacy | School of Pharmacy | Special Reference (RR) | 13/12/2019 | 2 | 2796.00 | 1 | 617.7061 THA/CHA | B4064 | 25/06/2025 | 27/12/2019 | 3495.00 | 13/12/2019 | Books |